ATE63817T1 - Mischungen von fu und bvu als adenokarzinomhemmende mittel. - Google Patents

Mischungen von fu und bvu als adenokarzinomhemmende mittel.

Info

Publication number
ATE63817T1
ATE63817T1 AT88200265T AT88200265T ATE63817T1 AT E63817 T1 ATE63817 T1 AT E63817T1 AT 88200265 T AT88200265 T AT 88200265T AT 88200265 T AT88200265 T AT 88200265T AT E63817 T1 ATE63817 T1 AT E63817T1
Authority
AT
Austria
Prior art keywords
bvu
adenocarcinoma
mixtures
agents
bromovinyl
Prior art date
Application number
AT88200265T
Other languages
English (en)
Inventor
Clercq Erik De
Masaaki Iigo
Original Assignee
Stichting Rega V Z W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W filed Critical Stichting Rega V Z W
Application granted granted Critical
Publication of ATE63817T1 publication Critical patent/ATE63817T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88200265T 1987-02-13 1988-02-12 Mischungen von fu und bvu als adenokarzinomhemmende mittel. ATE63817T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8700366A NL8700366A (nl) 1987-02-13 1987-02-13 Combinatie van fu met bvdu als middel tegen adenocarcinoom.
EP88200265A EP0283065B1 (de) 1987-02-13 1988-02-12 Mischungen von FU und BVU als adenokarzinomhemmende Mittel

Publications (1)

Publication Number Publication Date
ATE63817T1 true ATE63817T1 (de) 1991-06-15

Family

ID=19849574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88200265T ATE63817T1 (de) 1987-02-13 1988-02-12 Mischungen von fu und bvu als adenokarzinomhemmende mittel.

Country Status (8)

Country Link
US (2) US4894365A (de)
EP (1) EP0283065B1 (de)
JP (1) JP2688057B2 (de)
AT (1) ATE63817T1 (de)
DE (1) DE3862961D1 (de)
ES (1) ES2032942T3 (de)
GR (1) GR3002431T3 (de)
NL (1) NL8700366A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137724A (en) * 1990-05-23 1992-08-11 Stichting Rega Vzw Combinations of TS-inhibitors and viral TK-inhibitors in antiherpetic medicines
BR9607109A (pt) * 1995-02-01 1997-11-04 Fraunhofer Ges Forschung Emprego de 5'nucleosídeos substituidos para a formação de resisténcia no tratamento de citostáticos e medicamentos contendo estes nucleosídeos
JP2001512830A (ja) 1997-08-08 2001-08-28 ニューバイオティックス インコーポレイテッド 生物療法耐性および化学療法耐性を克服するための方法および組成物
IL137164A0 (en) 1998-01-23 2001-07-24 Newbiotics Inc Enzyme catalyzed therapeutic agents
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
BR0012676A (pt) 1999-07-22 2003-07-01 Newbiotics Inc Métodos para tratamento de tumores resistentes a terapia
WO2001045690A2 (en) * 1999-12-23 2001-06-28 Newbiotics, Inc. Use of bvdu for inhibiting the growth of hyperproliferative cells
DE10108851A1 (de) * 2001-02-23 2002-09-12 Resprotect Gmbh Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
DE3667915D1 (de) * 1985-01-30 1990-02-08 Hoffmann La Roche Pharmazeutische zusammensetzung.

Also Published As

Publication number Publication date
JPS63203619A (ja) 1988-08-23
GR3002431T3 (en) 1992-12-30
ES2032942T3 (es) 1996-07-16
US4988678A (en) 1991-01-29
JP2688057B2 (ja) 1997-12-08
DE3862961D1 (de) 1991-07-04
EP0283065A1 (de) 1988-09-21
US4894365A (en) 1990-01-16
EP0283065B1 (de) 1991-05-29
NL8700366A (nl) 1988-09-01

Similar Documents

Publication Publication Date Title
FR2781218B1 (fr) Compositions pharmaceutiques comprenant des 2-quinolones
ATE168560T1 (de) Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
TR200000437T2 (tr) Sinerjistik Biyosit bileşimi.
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
YU48528B (sh) Analozi 5-(1-hidroksi-2-piperidinopropil)-2-(1h,3h)-indolona
DE69714253D1 (de) Stickstoffoxydabgebendes präparat zur reduzierung der toxizität von wirkstoffen
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
ATE195401T1 (de) Synergistische mikrobizide mittel
GR3007385T3 (de)
DE3577984D1 (de) Alpha-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl)benzenacetonitrile.
ATE63817T1 (de) Mischungen von fu und bvu als adenokarzinomhemmende mittel.
ES2135472T3 (es) Antagonistas de angiotensina ii contra trastornos asociados con la velocidad de conduccion neuronal deteriorada, especialmente la neuropatia diabetica.
GR3005870T3 (de)
DK0865271T3 (da) Stabiliserede solbeskyttelsespræparater
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
FI911501A (fi) Liposomkomposition foer parenteralt bruk.
SU971075A3 (ru) Гербицидное средство
ATE89732T1 (de) Bakterientoetende gemische.
ATE93846T1 (de) S-substituierte beta-thioacrylamide und deren verwendung als mikrobizide.
ATE174911T1 (de) 1-dimethylcarbamoyl-1h-1,2,4-triazole- substituiert in stellungen 3 und 5
NZ503008A (en) Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or a salt thereof
DK189787A (da) Farmaceutiske praeparater til behandling af claudicatio intermittens
ES2058784T3 (es) Composiciones quimicas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee